How RWE can support drug development during COVID-19 and beyond
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
The COVID-19 pandemic introduced novel challenges for global biopharma organizations, as many...
COVID-19 has heightened the need for an expanded understanding of clinical trial populations and...
Thank you for visiting HealthVerity at Fierce 2025 HealthVerity had a fantastic week at Fierce Pharma Week 2025, connecting with agencies, pharma leaders, and innovators across the biopharma ecosystem. A special thank you to everyone who stopped by b...